MedPath

Cofnil

Brand Name: Cofnil

Generic Name: Salbutamol (as Sulfate) + Bromhexine Hydrochloride + Guaifenesin

Active
Registration Number

DRP-4624

Dosage Form

Syrup

Issuance Date

February 1, 2022

Expiry Date

February 20, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2mg/ 4mg/ 100mg per 10mL
Packaging60 mL Amber Bottle

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Bronchodilator/Mucolytic/Expectorant
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Salbutamol (as Sulfate)Active
Bromhexine HydrochlorideActive
Monograph: Bromhexine
GuaifenesinActive
Monograph: Guaifenesin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform